IN VITRO DRUG SUSCEPTIBILITY PATTERN OF MYCOPLASMA ALLIGATORIS ISOLATED FROM SYMPTOMATIC AMERICAN ALLIGATORS (ALLIGATOR MISSISSIPPIENSIS)

Abstract A recently described mycoplasma, Mycoplasma alligatoris, was isolated from dead American alligators (Alligator mississippiensis) that had demonstrated clinical signs of lethargy, anorexia, bilateral ocular discharge, edema, paraparesis, and polyarthritis. The in vitro minimum inhibitory concentration for nine antibacterial agents was determined through serial dilution in broth and plate culture for M. alligatoris isolates. The inhibitory concentration obtained for doxycycline, enrofloxacin, sarafloxacin, oxytetracycline, tilmicosin, and tylosin (<1 μg/ml) was lower than that of clindamycin (1–8 μg/ml), chloramphenicol (8–16 μg/ml), and erythromycin (32–138 μg/ml).

[1]  T. Schoeb,et al.  PATHOLOGY OF EXPERIMENTAL MYCOPLASMOSIS IN AMERICAN ALLIGATORS , 2001, Journal of wildlife diseases.

[2]  J. M. Farley,et al.  Mycoplasma alligatoris sp. nov., from American alligators. , 2001, International journal of systematic and evolutionary microbiology.

[3]  Calvin M. Johnson,et al.  MORBIDITY AND MORTALITY ASSOCIATED WITH A NEW MYCOPLASMA SPECIES FROM CAPTIVE AMERICAN ALLIGATORS (ALLIGATOR MISSISSIPPIENSIS) , 2009, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[4]  P. Hannan,et al.  Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. International Research Programme on Comparative Mycoplasmology. , 2000, Veterinary research.

[5]  P. Klein,et al.  Upper Respiratory Tract Disease in the Gopher Tortoise Is Caused by Mycoplasma agassizii , 1999, Journal of Clinical Microbiology.

[6]  D. Aucoin,et al.  Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs. , 1998, Journal of veterinary pharmacology and therapeutics.

[7]  C. Besch-Williford,et al.  A novel Mycoplasma sp. associated with proliferative tracheitis and pneumonia in a Burmese python (Python molurus bivittatus). , 1997, Journal of comparative pathology.

[8]  M. Runge,et al.  Mycoplasma crocodyli sp. nov., a new species from crocodiles. , 1997, International journal of systematic bacteriology.

[9]  F. Jordan,et al.  The minimum inhibitory concentration of tilmicosin and tylosin for mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks. , 1996, Avian diseases.

[10]  K. Mohan,et al.  Mycoplasma-associated polyarthritis in farmed crocodiles (Crocodylus niloticus) in Zimbabwe. , 1995, The Onderstepoort journal of veterinary research.

[11]  P. Klein,et al.  Mycoplasma agassizii causes upper respiratory tract disease in the desert tortoise , 1994, Infection and immunity.

[12]  M. J. Martín,et al.  Antibiotic sensitivity testing. , 1994, British journal of hospital medicine.

[13]  M. Verschure,et al.  Susceptibilities of Mycoplasma bovis, Mycoplasma dispar, and Ureaplasma diversum strains to antimicrobial agents in vitro , 1993, Antimicrobial Agents and Chemotherapy.

[14]  A. Pijpers,et al.  Comparison ofMethods forInVitro Testing ofSusceptibility of Porcine Mycoplasma Species toAntimicrobial Agents , 1991 .

[15]  F. Jordan,et al.  Effects of Baytril, Tylosin and Tiamulin on avian mycoplasmas. , 1989, Avian pathology : journal of the W.V.P.A.

[16]  K.,et al.  New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy , 1989, Antimicrobial Agents and Chemotherapy.

[17]  P. O'hanlon,et al.  In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. , 1989, Research in veterinary science.

[18]  L. Senterfit E16 – ANTIBIOTIC SENSITIVITY TESTING OF MYCOPLASMAS , 1983 .

[19]  P. Williams In Vitro Susceptibility of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis to Fifty-One Antimicrobial Agents , 1978, Antimicrobial Agents and Chemotherapy.

[20]  J. Tully,et al.  Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma. , 1977, Science.